you mean, on fewer sick adults, not 89% C/D, not to mention a small sample. You know this, we've had this discussion many times. Yet you make the claim. Another example of intentionally distorting the facts. It cant be compared, P1 vs P3.
And Fuji bought your lead product, and has not done a thing with it in over two years.
Can you come up with some different stories.
Anyway, I bought more today.
Ann: Appendix 4C - Quarterly, Strong Commercialization Revenues, page-155
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.030(2.67%) |
Mkt cap ! $1.275B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.14 | $1.09 | $3.345M | 3.007M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 33092 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 19704 | 11 |
View Market Depth
| Last trade - 14.40pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
-0.030 ( 3.89 %) |
||||
| Open | High | Low | Volume | ||
| $1.13 | $1.14 | $1.07 | 799243 | ||
| Last updated 14.59pm 05/06/2024 ? | |||||
| MSB (ASX) Chart |